Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-03
2009-06-16
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S210160, C514S212020, C514S220000, C540S466000, C540S543000
Reexamination Certificate
active
07547705
ABSTRACT:
The invention relates to a dihydrospiro-[cycloalkylamine]-pyrimidone derivative represented by formula (I) or a salt thereof:wherein: X, Y, R1, R2, R3, R4, o, m, n, p and q are as defined herein. The invention relates also to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3β, such as Alzheimer disease.
REFERENCES:
patent: 2005/0267132 (2005-12-01), Banville et al.
patent: WO 02/18386 (2002-03-01), None
patent: WO 03/027115 (2003-04-01), None
patent: WO 03/027116 (2003-04-01), None
Bhat, et al., J. Neurochem., 2004, 89, 1313-1317.
Martinez, et al., Med. Res. Rev., vol. 22, No. 4, 373-384 (2002).
Buée, et al., Brain Res. Rev., 33 (2000) 95-130.
Henriksen, et al., Curr. Drug Targets, 2006, 7 (11), 1435-42 (Abstract).
Gould et al., Curr. Drug Targets, Nov. 7, 2006(11): 1399-409 (Abstract).
Harwood, Curr. Mol. Med., Aug. 2003; 3(5): 472-82 (abstract).
Zhao, et al., Schizophr. Res., May 2006; 84(1). Epub Apr. 11, 2006 (Abstract).
Gould, Expert Opin. Ther. Targets, Jun. 2006; 10(3):377-92 (Abstract).
Kwok, et al., Annals of Neurology, vol. 58, No. 6, Dec. 2005, pp. 829-839.
Nadri, et al., Schizophrenia Research, 71 (2004), 377-382.
Vippagunta et al. Advanced Drug Delivery Reviews, 2001, 48, 3-26.
Griesser, Chapter 8, The Importance of Solvates (pp. 211-230), in the text, Polymorphism: In the Pharmaceutical Industry, Hilfiker, 2006.
Brittain, Chapter V of Polymorphism in Pharmaceutical Solids, 1999, pp. 126-127.
Chereze Nathalie
Lochead Alistair
Saady Mourad
Slowinski Franck
Yaiche Philippe
Berch Mark L
Gupta Balaram
Jaisle Cecilia M
Mitsubishi Pharma Corporation
Sanofi-Aventis
LandOfFree
Substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4072395